For patients with chronic kidney disease (CKD), the risk for emergently treated hypocalcemia with denosumab increases with ...

A new study published in the International Journal of General Medicine found that a severe vitamin D deficit (<10 ng/mL) ...

The Food and Drug Administration (FDA) has added a new boxed warning on the denosumab drug label (brand name: Prolia) to alert clinicians to an increased risk for severe hypocalcemia in patients with ...

Ketoanalogue supplements can enable patients to continue to meet their protein needs without exacerbating nitrogen load.

For patients with chronic kidney disease (CKD), the risk for emergently treated hypocalcemia with denosumab increases with ...

When patients have chronic kidney disease, the kidneys aren’t working as well to remove excess fluids, so it’s important to recognize medications that have the potential for fluid retention.

A recent study from the University of Hong Kong has found that sodium-glucose cotransporter 2 inhibitors (SGLT2i), a new type ...

In patients with renal insufficiency associated ... even in advanced chronic kidney disease; cysts derived from proximal tubules, but not those derived from distal tubules, contained increased ...

some diseases may cause the body's failure to metabolize or utilize Vitamin D very well. Patients with kidney disease are often unable to convert Vitamin D very well into its active form, which makes ...

The hypoparathyroidism treatment space has made a buzz in 2024 with a major drug approval, acquisitions, and big advances in ...